Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19340113 | 0.89 | CYP1A2 (0.37) | CYP1A2CA1CA9 | |
| SCHEMBL16675416 | 0.89 | TSHR (0.52) | TSHRALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL22193341 | 0.87 | TSHR (0.50) | TSHRALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL14003900 | 0.87 | TSHR (0.50) | TSHRALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL1104614 | 0.87 | CYP1A2 (0.36) | TSHRCYP1A2ALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL9999658 | 0.87 | CYP1A2 (0.36) | CYP1A2CA1CA9 | |
| SCHEMBL16663913 | 0.85 | TSHR (0.47) | TSHRALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL1104612 | 0.85 | CYP1A2 (0.35) | CYP1A2SMN1; SMN2 | |
| SCHEMBL15851165 | 0.83 | CYP1A2 (0.33) | CYP1A2SMN1; SMN2 | |
| SCHEMBL6553153 | 0.82 | TSHR (0.40) | TSHRALDH1A1TDP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180065948-A1 | Method for Synthesizing Cyclic Carbonates | HENKEL AG & CO. KGAA (DE) | 2018-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180065948-A1 | Method for Synthesizing Cyclic Carbonates | CA2, CA12, CA13 | TSHR 4590/4885CYP1A2 1836/4885ALDH1A1 4799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.